Starch Pros

December 03^rd 2025

CRISPR-Cas9 mediated editing of starch branching enzyme, SBE2 gene in potato for enhanced resistant starch for health benefits.

Researchers from Himachal Pradesh University, ICAR-Central Potato Research Institute, and ICAR-Indian Institute of Wheat and Barley Research in India have successfully developed high-amylose potatoes using CRISPR-Cas9. The team targeted two starch-branching enzyme genes, SBE2.1 and SBE2.2, in the widely grown potato variety Kufri Chipsona-I to increase its resistant starch content.

Using Agrobacterium-mediated transformation, the researchers generated 50 edited potato lines, 70% of which were found positive for bar and Cas9 genes. Six mutant lines, K301, K302, K303, K304, K305, and K306, exhibited deletions and substitutions in the target exons. Among these mutant lines, K304 was the most efficiently edited, containing both insertion-deletion and substitution mutations in three out of the four selected targets across both genes.

The study showed that the harvested tubers from the SBE2.1 and SBE2.2 mutant K304 line showed the highest amylose (95.91%) and resistant starch content (8.69 g/100 g). Further analyses revealed that these mutants illustrated an altered crystallinity index and a substantial decline in branch chain elongation in amylopectin. The researchers conclude that CRISPR-Cas9-mediated mutagenesis of starch biosynthesis genes is an effective strategy for developing potato varieties with improved nutritional profiles and health benefits.

For more information, read the study from “Frontiers in Genome Editing” (DOI 10.3389/fgeed.2025.1686412).

Source: https://www.isaaa.org/kc/cropbiotechupdate/article/default.asp?ID=21622

December 02^nd 2025

Scientists have developed a gene-editing technique that improves canola yield for farmers by introducing a particular starch-producing enzyme.

Scientists at the University of Guelph in Ontario, Canada, have developed a gene editing technique that improves canola yield for farmers by introducing a particular starch-producing enzyme into the crop’s genetic material.

According to the Manitoba Co-operator, the research took inspiration from a prior study which targeted thale cress — a genetically similar plant — by incorporating new genetic information drawn from maize DNA in order to encode the production of starch branching enzymes (SBEs). The inclusion of this SBE-linked genetic material was found to improve starch output, resulting in plants with greater overall biomass, typically in the form of thicker and denser stems and branches.

When applied to the canola crop, the same gene editing techniques similarly boosted canola seed yield and weather resilience without compromising on quality. In particular, this high-biomass canola has been demonstrated to perform well even under drought or heat-intensive conditions, at least under the controlled conditions in which these researchers have experimented so far.

In Canada, regulations on genetically edited crops have been loosening, and as of 2023, these crops face no more scrutiny than conventionally bred plants, per the Manitoba Co-operator.

Although many people sustain anxieties regarding the safety of genetically modified foods, most concerns are grounded in the rampant misinformation surrounding GMOs, when in reality, GMO crops must all be thoroughly vetted and pass certain safety standards before landing on our shelves. Decades of in-depth research on the subject have deemed the crops that pass these regulations safe for consumption.

On top of improving crop yield and safeguarding the livelihood of many farmers, gene editing research has helped scientists develop crops that demand less water, require little to no maintenance, and can withstand pests and disease outbreaks far more effectively than plants that are conventionally grown.

Especially as our pollution-heavy activities spur changes and instabilities in our weather patterns, it’s becoming more and more essential to fortify our food security in order to support our rising global population.

“I’ll just say genetic engineering … is a huge positive,” remarked Manitoba farmer Nicolea Dow, “and I see it as likely the most important tool for a future for agriculture that’s going to give us sustainability … [and] let us combat challenges, whether it be climate challenges or disease or insects or any kind of pests.”

The Guelph researchers have thus far limited their canola yield testing to controlled scientific environments, but the team should have more comprehensive, field-ready results by the summer of 2026, after further investigation into the crop’s yield, structure, and resilience.

Source: https://www.thecooldown.com/green-business/thrift-store-pricing-clothing-items-reddit/

November 23^rd 2025

14^th Asia Starch Value Chain & Fermentation.

When: 26-27 Feb, 2026, Bangkok, Thailand

Unlocking new opportunities across Asia’s starch value chain through sustainability, ingredient innovation, fermentation technologies and collaboration.

Thailand today stands at a pivotal moment in the evolution of the global tapioca starch industry, shaping not only regional markets but the world’s growing appetite for sustainable, versatile, and clean label starch solutions. The conference opens with a clear message: Thailand is more than a leading producer—its practices, policies, and innovations are positioning it as an international benchmark.

Dr. Dusit Pittayathikhun, President of the Thai Tapioca Starch Association (TTSA), opens by emphasizing Thailand’s strong farmer networks, responsible cassava cultivation, and advanced processing capabilities. These factors position the nation at the forefront of the transition toward a biobased economy.

Prof. Jono Newby of CIAT expands the view with a regional outlook on cassava production. Cassava’s resilience and versatility make it crucial for both food security and industrial applications, but evolving climate and market conditions require ongoing innovation and support for farmers.

A strategic panel featuring Dr. Werawat Lertwanawatana of Siam Modified Starch and Simon Bentley of Commoditia explores how climate challenges, market volatility, and global competition are pushing the cassava starch industry toward diversification and value-added products.

This theme continues with Dr. Siwarutt Boonyarattanakalin, who presents advances in modified tapioca starch for food and pharmaceutical applications, underscoring the importance of high-performance, clean-label ingredients.

Ingredient innovation is highlighted through sessions on cassava-based fibres by Sanguan Wongse Industries, sustainability-driven texturizing systems from Ingredion, and Agrocorp International’s shift toward plant-based dairy ingredients using pea protein and starch derivatives.

Sustainability plays a major role as Dole Specialty Ingredients demonstrates how banana and pineapple residues can be upcycled into valuable starch-based ingredients, and A*STAR discusses alternative feedstocks for precision fermentation.

Prefer and Pure Mylk present further opportunities: converting fermented byproducts into coffee ingredients and turning regional crops into plant-based beverage bases.

The event concludes with a panel led by Santi Abakaz of the Future Food Network, exploring AI-driven flavor innovation and the rise of fermentation-enabled alternative proteins. Collectively, the sessions reveal how Thailand and Asia are reshaping the global starch landscape through innovation, circularity, and collaboration.

For more details, like the event agenda, follow the link below.

Source: https://www.cmtevents.com/aboutevent.aspx?ev=260205&

November 20^th 2025

Dei Biopharma opens a $50 million cassava plant in Namasagali, Kamuli (Uganda).

Uganda’s quest for pharmaceutical self-reliance is set to take a decisive step this month when Dei Biopharma commissions a cassava starch manufacturing plant in Namasagali in the eastern district of Kamulu.

The 50-million-dollar investment marks the first phase of what the company describes as the “Dei Group Advanced Agro-processing Park” – an ambitious industrial zone designed to supply locally manufactured excipients and active pharmaceutical ingredients (APIs) to the firm’s manufacturing complex in Matugga near Kampala.

The facility, to be commissioned by President Yoweri Museveni on November 20, 2025, will serve both as a lifeline for farmers and a cornerstone for local production of pharmaceutical ingredients. On the same day, President Museveni will also commission Dei Group’s organic fertilizer plant at Nansololo, also in Kamuli, also a project in the park.

The founder and managing director of Dei Biopharma, Dr. Matthias Magoola, says, “We are among the first companies in Africa to manufacture our own excipients and active pharmaceutical ingredients”, adding that “Our decision to invest in start production is strategic – to make Uganda competitive in drug manufacturing by reducing dependence on imported inputs”.

According to Dr. Magoola, Africa imports up to 85 percent of all essential medicines, mainly because the continent lacks facilities capable of producing base pharmaceutical ingredients.

“Almost 99 percent of the starch and other excipients used in tablet and capsule production are imported. That makes local manufacturing expensive and uncompetitive. By producing our won starch, glucose, and malt sugars here, we close a critical cost gap”, said Dr. Magoola.

Namasagali was chosen for both its geography and logistics. Located along the banks of River Nile and close to Lake Kyoga, the site connects easily to major cassava-growing regions in northern Uganda, eastern Uganda, and even the Democratic Republic of Congo.

For Uganda’s cassava farmers, particularly those in the regions of Busoga, Bukedi, Lango, and Teso, the cassava starch plant presents a new and reliable market.

The plant will require about 500 metric tonnes of cassava daily, the equivalent of produce from 50 acres daily, providing significant alternative to sugarcane farming, which has dominated the area for decades.

Dei Biopharma has already registered over 3,000 farmers and distributed planting materials for Nilocus-1, a high-yield cassava variety developed by Ugandan crop scientists.

Says Dr Magoola: “Our goal is to ensure consistent raw material supply while improving farmer incomes. A farmer growing cassava will earn roughly triple what a sugarcane farmer earns on the same piece of land, because cassava has a shorter growing cycle and higher returns per kilogram. They also sell stems for planting, so it is a win-win”.

The company is working with agricultural extension officers to tarin farmers in modern cassava cultivation and post-harvest handling.

While starch is the plant’s flagship product, its applications stretch far beyond pharmaceuticals.

Dei Biopharma is now producing glucose, maltose (malt sugar) and two grades of fructose – all key ingredients in beverage, food, and drug manufacturing. They will also extract sorbitol, marnitol, and dextrose.

Dr. Magoola says they are starting with five products, but will eventually extract over 100 derivatives from cassva, maize, and potatoes.

The company’s facility includes technology to modify starch for specialized uses and to produce Vitamin C and other sugar derivatives critical in pharmaceutical production.

Once the United States Food and Drug Authority approves, Dei Biopharma will start exporting starch and other intermediaries to markets across Africa and the global South.

Says Dr. Magoola: “When our starch secures FDA certification, Uganda will not only meet local demand but also export pharmaceutical-grade starch to other countries”.

According to Dr. Magoola, cassava offers dual benefits – both food and income. He says when you grow cassava or maize, you can sell to the factory and still keep some for your own household, adding that it is an approach that addresses food and income security simultaneously.

The starch factory is only one part of Dei Biopharma’s broader agro-industrial blueprint.

On the 5,000-acre estate, the company is developing a fully-integrated hub that will include a fertilizer plant producing organic inputs from animal waste and a biotechnology complex for veterinary vaccines.

“We are constructing a Foot and Mouth Disease (FMD) vaccine facility with capacity to produce 100 million doses annually, and it is already 50 percent complete.

“We will also produce vaccines for poultry and swine fever using formulations we have developed locally”, says Dr. Magoola.

By developing an end-to-end manufacturing chain – from farm to finished pharmaceutical product – Dei Biopharma aims to position Uganda as a regional centre for biopharmaceutical innovation and agro-industrial exports.

Dr. Magoola describes it as an “advanced park” because, unlike most agro-processing facilities in Africa, it focusses on extracting high-value compoents such as modified startch and API precursors.

Dei Biopharma’s Matugga facility, partly operational, has 30 production plants designed to manufacture a range of essential medicines – from intravenous fluids to oncology drugs and drugs for other rare diseases.

The addition of the Namasagali starch plant completes a key part of the supply chain – ensuring raw materials are locally sourced, costs are reduced, and production becomes globally competitive.

According to Dr. Magoola, the ultimate goal is to make quality medicines affordable to every Ugandan and every African.

“By controlling our inputs and manufacturing locally, we save foreign exchange, build industrial capacity, and create thousands of decent jobs”, he says.

Commissioning of the starch plant signals a shift from dependency to production; from importing what Africa needs to building what Africa can export.

For the country’s farmers, scientists, and industrialists, the launch of the Namasagali starch plant marks the beginning of a new kind of value chain, where agriculture and science converge to power national growth.

Source: https://ugandainvest.go.ug/ugandan-pharmaceutical-investor-unveils-50m-cassava-starch-plant/

November 18^th 2025

Sweden and Denmark advance CRISPR-edited starch potato trials.

Project Oppotunity, a collaboration of 12 European organisations in the starch potato chain, has completed its first field trials with CRISPR-Cas-edited starch potatoes developed for late blight resistance. The 2025 trials took place in Sweden and Denmark and were accompanied by a seed multiplication program to supply material for larger trials in 2026.

According to the project, the gene-edited lines were created using CRISPR-Cas applied to Kuras, a widely used European starch variety provided by Agrico. Hans Berggren, secretary of Project Oppotunity, said, “Only last year we created the first seedlings and cultivated them in a greenhouse to produce seed-tubers, and have now grown these so-called mini-tubers in the field during the 2025 growing season.” He added, “I’m very optimistic that by 2026 and onwards, we can show stakeholders the power of NGTs in the field via enhanced potato genotypes tolerant to a plant disease as severe as late blight. We have proven the speed this technology brings to adapt potatoes to urgent and changing environmental requirements.”

Seed multiplication was carried out in parallel to generate larger volumes of seed potatoes for multi-location trials in 2026. These will measure resistance levels and agronomic performance under commercial-style management.

Late blight caused by Phytophthora infestans remains a key constraint for potato growers, who often apply multiple fungicide sprays each season. New pathogen strains continue to emerge, creating pressure on existing chemistry and resistance sources. Oppotunity position gene-edited resistance as a tool to reduce fungicide reliance if EU rules for new breeding methods allow the use of NGTs in commercial production.

Sjefke Allefs, potato breeder at Agrico and project partner, said, “It will still take some years to verify the effects and select the single event that will deliver an appropriate increased late blight tolerance so that it contributes to a more sustainable starch potato cultivation.” He added that the overall process is “8–10 years faster than what can be achieved with traditional breeding.” By directly editing a resistance trait into Kuras rather than relying on repeated crossing, the partners aim to preserve existing agronomic and processing characteristics while adding targeted disease tolerance.

Project Oppotunity includes Aardevo, Agrana, Agrico, Emsland Stärke, Finnamyl (Chemigate), KMC, Lyckeby, Niehoff, Norika, SolEdits, Südstärke and AKV. The group aims to maintain the competitiveness of the European starch potato sector and supports a regulatory framework in which certain gene-edited plants are treated the same as conventionally bred varieties.

With seed stocks now increased, the consortium will move to broader 2026 trials to assess late blight pressure, resistance levels, yield, starch characteristics, and fungicide requirements compared with standard Kuras and other commercial checks. Performance data and the evolving EU regulatory framework will determine whether an edited line progresses toward commercialisation and whether the approach could be applied to other starch varieties.

Source: https://www.freshplaza.com/latin-america/article/9785612/sweden-and-denmark-advance-crispr-edited-starch-potato-trials/

October 23^rd 2025

Trade Kings Group commissions Zambia’s first glucose and starch plant.

• Zambia inaugurated its first glucose and starch factory, a $110 million investment by Kingsworth Group Limited, a subsidiary of Trade Kings Group.
• The plant will process 126,000 tons of maize annually to produce glucose, starch, and animal feed by-products.
• The project aims to reduce Zambia’s $15 million annual imports of glucose and starch and strengthen local industrial capacity.

Zambian President Hakainde Hichilema on October 21 inaugurated the country’s first industrial glucose and starch production plant in the Lusaka South Multi-Facility Economic Zone (MFEZ). The $110 million facility was financed by Kingsworth Group Limited, part of the Zambian conglomerate Trade Kings Group.

The new factory marks a milestone for Zambia’s industrial sector, which has seen strong growth in food and beverage production. The facility will manufacture glucose and starch for use in the agro-processing and manufacturing industries, as well as animal feed by-products.

Although production capacity figures were not disclosed, company officials said the plant will process about 126,000 tons of maize each year.

Phil Daka, Trade Kings Group’s Executive Director for Corporate Affairs, said the plant will source maize from local farmers. “We are celebrating not only a factory, but an idea whose time has come,” Daka said. “This investment positions Zambia as the third producer of glucose and starch in Africa, after Egypt and South Africa.”

The project aims to strengthen local value chains and substitute imports to meet Zambia’s rising domestic demand for industrial ingredients. Between 2022 and 2024, Zambia imported an average of $11.7 million worth of glucose and $3 million of starch annually, according to Trade Map data.

Source: https://www.ecofinagency.com/news-industry/2310-49780-zambia-commissions-first-glucose-and-starch-factory

October 19^th 2025

Engineers built a new kind of concrete 2x stronger than the real thing.

The secret ingredient? Potato starch.

Engineers from the University of Manchester say their concrete is twice as strong as conventional concrete. The engineers believe future space construction will need this solution.
Potato starch replaces human blood as a key ingredient in the new recipe.
The University of Manchester’s “StarCrete” is twice as strong as traditional concrete, making it a potential solution as a building material for Mars. Add in some extraterrestrial dust and potato starch, and you have a potentially revolutionary new material.

In an article published in the journal Open Engineering, the research team showed that potato starch can act as a binder when mixed with simulated Mars dust to produce a concrete-like material reaching a compressive strength of 72 megapascals (MPa), over twice as strong as the 32 MPa seen in ordinary concrete. Of course, mix in moon dust instead and you can get StarCrete to 91 MPa.

This strength makes it a possible solution, according to the researchers, for a building solution on Mars as astronauts mix Martian soil with potato starch—and a pinch of salt, no joke—to give extra-terrestrial-suited concrete.

Earlier recipes from the team didn’t use potato starch, instead offering blood and urine as a binding agent to reach 40 MPa. Not every astronaut would be excited about continually draining their blood to build in space, though.

“Since we will be producing starch as food for astronauts, it made sense to look at that as a binding agent rather than human blood,” Aled Roberts, research fellow at the Future Biomanufacturing Research Hub and lead researcher on the project, says in a news release. “And anyway, astronauts probably don’t want to be living in houses made from scabs and urine”

Source: https://www.popularmechanics.com/space/moon-mars/a69031878/new-concrete-is-twice-as-strong/ and https://www.degruyterbrill.com/document/doi/10.1515/eng-2022-0390/html

October 13^th 2025

Across the Middle East and Africa, the corn starch market was valued at approximately $1.3 billion in 2024.

Al Ghurair Foods, a division of the Al Ghurair Group — one of the UAE’s most diversified and pioneering business conglomerates — has announced the phased completion of the nation’s first-ever corn starch plant at Khalifa Economic Zones Abu Dhabi (Kezad) by the first quarter of 2026.

Speaking at the inauguration of Propaper 2025 — the region’s leading B2B paper industry event in Dubai — Hamad Al Ghurair, vice-president of Al Ghurair Foods, said the project’s major civil and mechanical, electrical, and plumbing (MEP) works have been substantially completed. Installation of processing equipment is currently underway, paving the way for a phased launch in early 2026. “We are targeting the rollout of our flagship corn starch product in the first quarter of 2026, followed by the introduction of additional products in subsequent phases,” Al Ghurair said.

The Kezad-based facility, spanning 13.6 hectares, will significantly reduce the UAE’s dependence on imported starch — currently valued at about $20 million annually. Once operational, it will supply local industries with a reliable, high-quality, and cost-effective alternative, enabling greater resilience in key manufacturing sectors. “Our primary focus will be on serving domestic and GCC markets while exploring opportunities in South Asia and key African economies,” Al Ghurair noted.

Corn starch is a critical input across multiple industries including food, pharmaceuticals, textiles, chemicals, packaging, and paper. Within the paper industry, starch enhances strength, printability, and coating quality — making it indispensable for manufacturers aiming to improve both performance and sustainability. “By establishing local starch production, we are strengthening the region’s industrial supply chains and supporting the shift toward greener, circular manufacturing models,” said Al Ghurair.

Across the Middle East and Africa, the corn starch market was valued at approximately $1.3 billion in 2024, with the UAE’s share at nearly $30 million. Analysts say demand is being driven by population growth, industrial diversification, and increasing preference for biodegradable and sustainable materials. The Al Ghurair facility, once operational, will position the UAE as a regional hub for starch production and downstream innovation.

The launch coincides with a regional pivot toward sustainability and recycling, particularly within the paper sector. Propaper 2025, which runs from October 13 to 15, has placed a strong emphasis on the circular economy, renewable energy, and waste reduction strategies. “Paper mills across the GCC are investing in renewables and recycling to mitigate their climate impact,” said Jeen Joshua, managing director of Verifair, the event organiser. “The rapid growth of Material Recovery Facilities and smaller sorting units feeding regional mills reflects the serious intent behind these sustainability efforts.”

According to industry estimates, cumulative investments in paper recycling and innovation projects across the GCC have reached nearly $200 million. The UAE, Saudi Arabia, and Oman lead this drive with major investments by Star Paper Mills ($54 million), Oman’s Kreyas Paper ($40 million), and MEPCO in Saudi Arabia. Other key projects include $5.5 million by Kimfay East Africa and $2.5 million by Tetra Pak–Union Paper Mills in Egypt.

Data from ENF Recycling indicates that there are now between 80 and 100 paper recycling plants operating across the Middle East and Africa, reflecting growing industry maturity. Grand View Research estimates the region’s waste recycling services market to be worth $3.46 billion by 2033, with the recycled paper segment alone valued at $715.6 million, according to Sper Research.

The convergence of industrial innovation, sustainability, and import substitution reflected in Al Ghurair’s Kezad project underscores the UAE’s industrial vision under the “Make it in the Emirates” initiative. As the country diversifies beyond hydrocarbons, such ventures are redefining its manufacturing base — anchoring future growth in value-added, sustainable industries, analysts said.

Source: https://www.khaleejtimes.com/business/al-ghurair-to-launch-uaes-first-corn-starch-plant-in-kezad

October 01^st 2025

8th Annual EUstarch value chain and fermentation October 13-14 Berlin (Germany).

Agenda:

Day 1
12:30
Registration & Networking Lunch
13:25
Chairman’s Welcoming Remarks
Simon Bentley, Managing Director
Commoditia Ltd
13:30
Strengthening starch’s central role in the EU bioeconomy: Policy pathways for resilience, competitiveness, and market expansion
Nellie Hajdu, Managing Director
Starch Europe
14:00
EU wheat starch and vital wheat protein market
Michael Andreae Jaeckering, Owner
Jaeckering Mühlen- und Naehrmittelwerke GmbH
14:30
European potato starch market
Andre Heilemann, Head of R&D
Emsland-Stärke Gmbh
15:00
Discussion followed by Tea
15:45
Feeding the Future Starts With Seeing Clearly: How LCA and Transparency Guide Sustainable Land Use
Dick van Beek, CEO
Aminola
16:15
New clean label technology to modify starch
Dr. Jovin Hasjim, Research and Development Engineer
Roquette
16:45
Innovative egg replacer solutions with peas
Cyril Francart, CEO
FlavaPulse
17:15
Final Discussion. End of Day One. Followed by Networking Reception

Day 2
09:00
Chairman’s Welcome Remarks
Henk Jaap Meijer, Director & Owner
Meijer Consult BV
09:10
Macro and microeconomic forces shaping the starch value chain in a volatile blend of risk, tariffs disruption, and shifting demand patterns
Simon Bentley, Managing Director
Commoditia Ltd
09:40
Chemo-enzymatic extraction of dietary fibres from corn processing
Prof. Francisco Vilaplana, Director of Food
KTH Royal Institute of Technology
10:10
Discussion. Followed by Coffee Break
10:50
Valorising starch-based side streams into biomaterials
Dr. Anne Lamp, CEO & Co-Founder
traceless materials GmbH
11:20
Fermentation of food waste streams (potato processing) into
i) Fatty acids; Scalability & LCA and carbon savings
Niels van Stralen, Founder & Chief Growth Officer
ChainCraft BV
ii) Oil & Fats
Jeroen Hugenholtz, Chief Technology Officer
NoPalm Ingredients B.V.
12:10
Development of new applications and products for plant-based residual from petfood, feed to renewable chemicals
Gert-Jan Hermanussen, Head of Procurement
Looop Company
12:30
Discussion followed by Lunch
14:00
Sustainable protein consumption via fermentation processes
i) Can precision fermentatively produced protein be the next big thing?
Will van den Tweel, Project director
Those Vegan Cowboys
ii) Biomass fermentation of yeast to provide stability, protein loading and more to condiments & beverages
Tomas Turner, CEO | Co-Founder
Cosaic
15:00
Leveraging fermentation technology & combined AI to transform agricultural byproducts into nutritious and sustainable ingredients
Bosco Emparanza Garcia, CEO & Founder
Moa Foodtech
15:30
Clean label mycoprotein solutions from valorised agriwaste streams
Iria Varela Campo, CEO & Cofounder
ODS Protein
16:00
Final Discussion. Tea
17:00
End of conference

Source: https://www.cmtevents.com/eventschedule.aspx?ev=251017&

August 26^th 2025

Kazakhstan to launch starch and dextrine plant.

A corn deep processing plant with a capacity of 150,000 tons a year will be launched in Turkistan region in 2025, Kazinform News Agency cites the Kazakh Agriculture Ministry.

The plant will manufacture 20 types of products, including starch, treacle, edible dextrose, malt sugar syrup, corn oil, gluten, mill offals and grain-rich feed-stuff. It will use exclusively non-GMO corn in its production.

The facilities designed to receive, dry, and store raw material have already been commissioned.

Works are currently underway to commission production capacities and implement waste-free processing technology.

The total investment amount will reach 35 billion tenge.

Noteworthy, Kazakhstan will spend KZT 200 bln to develop 154 agro-industrial projects.

Source: https://qazinform.com/news/kazakhstan-to-launch-starch-and-dextrine-plant-b057e0